Consumer Health

In the United Arab Emirates, analgesics can be categorised into two groups: products from international brands, and those from regional brands, which tend to be priced lower. By the end of the review period, the majority of analgesics brands were…

There are interesting developments in terms of diverging performances within adult systemic analgesics. In 2023, acetaminophen is set to drive current value growth, and significantly outpace the overall performance of adult analgesics. Growth in…

The pandemic boosted demand for analgesics in Vietnam, as consumers believed that it was necessary to store analgesics at home as a precautionary measure. Adult and paediatric acetaminophen performed particularly well in 2020 and 2021, as…

The overall picture is expected to be positive in consumer healthy in 2023, as the economy performs well. The increase in natural gas export prices has helped offset the dip in oil prices. However, inflation remains high and the currency has devalued…

During 2023, Argentina was plunged into an economic crisis, with the rate of inflation soaring to more than 100%, one of the highest in the world. With the country already struggling to comply with the conditions of a loan package from the…

In Bangladesh, consumer health faces the challenge of inflation across various categories in 2023. Meanwhile, consumer preferences are shifting towards modern medicine due to its perceived quick effectiveness, leading to a decline in demand for…

Consumer health in Belgium continues to see steady growth in current value terms in 2023, albeit at a slightly slower pace than in the previous year. Among the most dynamic categories are analgesics, sleep aids (driven by high stress levels among the…

Bolivia has managed to protect itself to a large extent from inflation by continuing to have a fixed exchange rate against the dollar. However, there has been challenges for the economy in 2023, with sharp falls in foreign currency reserves and this…

In 2023, consumer health is no longer influenced by the COVID-19 pandemic, as everyday life has normalized in Bosnia and Herzegovina. Some categories, such as cough, cold allergy (hay fever) remedies, which were negatively impacted during the…

In 2023, still relatively high inflation continues to impact prices of essentials, such as groceries, as well as consumer health products, including OTC remedies, vitamins and dietary supplements and sports nutrition. However, consumer demand remains…

Consumer health in Chile experienced a notable slowdown in value growth in 2022 compared to the previous year's performance. In 2021, the pandemic-induced liquidity in the local market and the shift towards preventive habits among consumers drove…

Consumer health in China recorded high single-digit current value growth in 2022, mainly due to the COVID-19-related sales surge for OTC products, and this growth trend is set to continue in 2023, mainly due to rising health awareness. In terms of…

In 2023, Colombians returned to their familiar routines, with increasing social activity and hectic lifestyles leading to an increase in cases of cold and benefiting most OTC categories. However, the opposite trend is being observed in vitamins and…

With high inflation as a result of the war in Ukraine, as well as the aftermath of COVID-19, prices have risen sharply, driving value sales growth in consumer health in Croatia. Volume sales, meanwhile, are beginning to return to their pre-pandemic…

Consumer health in Denmark is registering solid current value growth in 2023, albeit at a slightly slower rate than seen in the latter half of the review period; however, this growth is partly driven by strong inflation, which has resulted in price…

Despite persistent inflationary pressures in the country and wages that have not yet caught up with market conditions, consumer health recorded growth in 2023. Growth was supported by solid categories, including cough, cold and allergy (hay fever)…

Ecuador is expected to register only a slight increase in current value sales in 2023. Ecuador is grappling with rising crime rates and political instability, with runoff elections scheduled in October. This is all leading to economic uncertainty and…

Consumer health in France continues to experience growth in 2023. Due to the pandemic, consumers’ immune systems have been negatively impacted. The French healthcare system remains weak and 2022 and 2023 have faced multiple challenges, including a…

Inflation is a key factor influencing the consumer health market in Greece, with price hikes being seen across most categories. Even though increases in prices vary by brand, most products have been subject to hikes. This has not had the same effect…

Consumer health is witnessing another strong performance in 2023 as the category continues to recover from the COVID-19 pandemic following the removal of all pandemic-related restrictions. As Irish people shift back to normal living habits without…

Consumer health is expected to register a healthy pace of current value growth in 2023. After a successful vaccination programme in 2021, society opened up quickly in Israel. With society returning to greater normality in 2023, common illnesses are…

Consumer health is set to record moderate single-digit growth in current value terms in 2023. With the pandemic officially over, according to the World Health Organisation (WHO), Italians are keen to get back to their pre-COVID-19 lifestyles and this…

Total current value sales growth for consumer health in Morocco in 2023 is expected to be up considerably on 2022. While this is partly due to inflationary pressures fuelled by the global recovery from the pandemic and the fallout of Russia’s…

2023 saw a repeat of the moderate, sustainable growth that was registered in most categories of consumer health during 2022, with the prevailing background trends characterised by a return to some semblance of pre-pandemic normality in the daily…

The Coronavirus (COVID-19) pandemic had a major impact on almost every category within consumer health in the Netherlands. While the COVID-19 situation eased by 2022, 2023 is the first full year after the pandemic in which players, retailers and…

2023 is set to be a strong year for consumer health in the United Arab Emirates. Many categories are expected to see robust current value growth, underpinned by an increase in online distribution channels, as well as an increasingly savvy,…

While 2022 was characterised by high inflation, persisting supply chain constraints, and the ongoing war in Ukraine, which brought price increases and volume declines across much of consumer health, it benefited from waning COVID-19 cases and the…

Current value sales of consumer health in Vietnam continue to record strong growth in line with the rising trend of health and wellness in the country. Post-pandemic, the majority of Vietnamese consumers are taking greater care of their health, and…

Cough, cold and allergy (hay fever) remedies are expected to perform better in 2023 than in the previous year, with positive value and volume growth. As life in Algeria returns to normal, and social contact increases, there is increased coughs, colds…

Retail sales of cough, cold and allergy (hay fever) remedies saw another year of healthy growth in constant value terms in 2023. With the resumption of pre-pandemic lifestyles, including a return to work, school and social activities, consumers…

Sales of cough, cold and allergy (hay fever) remedies are seeing strong growth in current value terms in 2023. This is partly due to inflation-driven price increases (also the consequence of supply shortages in some cases) and an increase in cough,…

Seasonal flus have returned, as people mix together once again , post pandemic, and cough, cold and allergy (hay fever remedies) are expected to register moderate current value growth, though constant value growth will be minimal, as rising costs hit…

Cough, cold and allergy (hay fever) continues to rebound following the declines during the COVID-19 pandemic and the slow recovery in its aftermath. Unit prices have been driven up by inflation resulting in double-digit current value growth in 2023,…

Cough and cold remedies/products are expected to enjoy demand in 2023. However, the shortages of cough and cold medicines, which provided a consistent disruption in 2022, lingered in 2023. Against this background, manufacturers have struggled to keep…

Cough, cold, and allergy (hay fever) remedies in Chile is experiencing remarkable growth for the second consecutive year in 2023, both in terms of volume and value. This upward trend can be attributed primarily to the return to normalcy following the…

Even though cough, cold and allergy (hay fever) remedies recorded over 40% current value growth in 2022, it is anticipated that the category will continue to achieve high single-digit growth in 2023. Starting from late 2022, the end of the zero-COVID…

In 2022, demand for cold, cough and allergy (have fever) remedies soared, as a result of the atypical increase in flu cases, as social distancing, handwashing protocols, and the use of face masks were totally lifted in 2022, facilitating the spread…

During the last couple of years, the flu season was virtually non-existent as a result of Croatians staying at home and, when venturing out in public, wearing face masks, maintaining social distance and frequently washing their hands. This…

Cough remedies and decongestants, which had seen strong growth during the pandemic period, saw more moderate growth in 2022 and 2023 as the contagion receded and public concern waned. Current value sales growth partly reflects inflationary pressures,…

Cough, cold and allergy (hay fever) remedies are among the most popular consumer health items in the Dominican Republic and are experiencing further growth in 2023 despite higher unit prices resulting largely from persistent inflationary pressures…

Cough, cold and allergy (hay fever) remedies are expected to register a decline in value sales. Value sales are now at more normal levels, as concerns about the COVID-19 virus have abated. In addition, Ecuador is grappling with rising crime rates and…

Within OTC consumer health in France, value sales of cough, cold and allergy (hay fever) remedies are continuing to record the fastest growth in 2023, following a dynamic performance the previous year. Within the category, demand for various formats…

In May 2022, Greece lifted all COVID-19 related regulations. This included the compulsory use of face masks and social distancing rules, and although use of face masks remains fairly high in Greece compared to other European countries, it appears…

Cough, cold and allergy (hay fever) remedies are enjoying strong growth in 2023 as the category continues to recover from the sharp declines seen during the COVID-19 pandemic. Flu, common coughs and colds and seasonal allergies in the Irish…

The normalisation of consumer lifestyles has hastened the return of common coughs and cold in Israel, with a notable uplift in schools. In April 2022, the mask mandate was removed, aside from specific locations such as hospitals and medical clinics,…

Cough/cold remedies are set to see high single-digit growth in current value terms in 2023, with sales likely to benefit from a high number of cases of cold and flu in the 2023/2024 season. Furthermore, value sales will likely also be boosted by unit…

Overall demand for cough and cold remedies in Morocco has picked up in 2023, with most categories set to register improved results in volume growth terms as compared to 2022. The use of these products has been buoyed by the easing of the pandemic and…

Cough, cold and allergy (hay fever) remedies remains the largest OTC category in Norway, accounting for more than one-third of total OTC value sales in 2023. Despite the already relatively high penetration of these products, the category registered…

Cough, cold, and allergy (hay fever) remedies is projected to continue to post retail current value growth in 2023, following a severe decline in 2020 due to the Coronavirus (COVID-19) pandemic. Having passed the 2019 pre-pandemic level in 2022, the…

In 2023, cough, cold and allergy (hay fever) remedies is set to see dynamic current growth, on top of an extremely strong performance in 2022. Within the category, after medicated confectionery, growth is set to be driven by and paediatric cough/cold…